Advertisement

Topics

LTS LOHMANN Therapie-Systeme AG Company Profile

01:45 EST 11th December 2018 | BioPortfolio

LTS was originally a subsidiary of the Lohmann Group. Lohmann was founded in 1851 and is active in a wide range of business areas, including medical products, adhesive tape systems and nonwoven fabrics.LTS Lohmann Therapie Systeme is now an independent company and was founded in 1984 for the purpose of developing and producing drug delivery systems.
For the past 20 years LTS, has enjoyed an impressive period of growth to become one of the world's leading suppliers of transdermal and oral systems for the international pharmaceutical industry.

Location

Lohmannstraße 2
Andernach
D-56626
Germany

Contact

Phone: 49 (0) 2632 99-0
Fax: 49 (0) 2632 99-2200
Email: ltsgroup@ltslohmann.de


News Articles [47 Associated News Articles listed on BioPortfolio]

Steba Biotech's VTP-Therapie mit TOOKAD® hält deutliche Verringerung der Gesamtprogression ...

Steba Biotech, ein Biotechunternehmen in Privatbesitz, das auf die Entwicklung innovativer und minimalinvasiver photodynamischer Therapien und Systeme zur Behandlung von Krebs spezialisiert ist, gab...

Novartis erhält Zulassung für CAR-T-Zell-Therapie Kymriah in der EU

Basel (awp) - Novartis hat für seine Zell-Therapie Kymriah die Zulassung von der Europäischen Kommission erhalten. Die Zulassung betrifft zwei sogenannte B-Zell-Malignome: einerseits die akute lymp....

QIAGEN und NeuMoDx kündigen strategische Partnerschaft zur Vermarktung der nächsten Generation voll integrierter molekularer Diagnostiktests an

QIAGEN führt zwei "Sample to Insight"-Systeme in Europa und auf anderen Märkten ein; NeuMoDx vermarktet in den USA Erstes Testmenü für Infektionskrankheiten und LDTs QIAGEN N.V. (NYSE: QGEN; Frank...

Novartis International AG: Novartis erhält die Zulassung für seine CAR-T-Zell-Therapie Kymriah (Tisagenlecleucel) von der Europäischen Kommission

Novartis International AG / Novartis erhält die Zulassung für seine CAR-T-Zell-Therapie Kymriah (Tisagenlecleucel) von der Europäischen Kommission . Verarbeitet und übermittelt durch Nasdaq Corpor...

DGAP-News: Gerresheimer AG: Mikropumpe für die Parkinson-Therapie der Gerresheimer Tochter Sensile Medical erhält europäische CE-Deklaration (deutsch)

Gerresheimer AG: Mikropumpe für die Parkinson-Therapie der Gerresheimer Tochter Sensile Medical erhält europäische CE-Deklaration DGAP-News: Gerresheimer AG / Schlagwort(e): Markteinführung/Zulass...

MorphoSys schlägt ein neues Kapitel auf!

MorphoSys forciert derzeit den Aufbau einer US-Tochtergesellschaft. Ein Ziel: die Vermarktung des hauseigenen Wirkstoffprogramms "MOR208" zur Therapie von Blutkrebs in den USA. Hierfür will man die.....

OWC Pharmaceutical Research Corp. plant Treffen mit Investoren, Wissenschaftlern und ...

RAMAT GAN, Israel, November 7, 2018 /PRNewswire/ -- Im Anschluss an die vor Kurzem verkündeten Testerfolge einer innovativen Verabreichungsform bei der Therapie von multiplen Myelomen Read more...

Novartis erhält EU-Zulassung für Gen-Therapie Luxturna bei Sehverlust

(Meldung ausgebaut)Basel (awp) - Novartis sichert sich im Bereich der Gentherapie erneut eine Vorreiterrolle. Wie der Konzern am Freitag mitteilte, hat er von der EU-Kommission grünes Licht für Lux....

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Qutenza [NeurogesX, Inc.]

These highlights do not include all the information needed to use QUTENZA safely and effectively. See full prescribing information for QUTENZA. QUTENZA (capsaicin) 8% patch Initial U.S. Approval: 200...

Nitroglycerin [Kremers Urban Pharmaceuticals Inc.]

Nitroglycerin Transdermal System

PubMed Articles [29 Associated PubMed Articles listed on BioPortfolio]

S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 1 - Systemische Therapie.

Measurement of three-dimensional wavefronts using the Ichikawa-Lohmann-Takeda solution to the irradiance transport equation.

In this paper, we use the irradiance transport equation and the Fourier transform-based experimental solution given by Ichikawa-Lohmann-Takeda. We analyze experimental factors such as the digital filt...

Influence of lauric acid on the susceptibility of chickens to an experimental Campylobacter jejuni colonisation.

Among the organic acids, lauric acid has shown a high level of in vitro activity against Campylobacter jejuni. The prevalence and intensity of C. jejuni excretion at slaughter often becomes lower with...

Leukocytosis during pirfenidone therapy: A case report.

Adjuvante Behandlung des schweren/refraktären bullösen Pemphigoids mit Protein-A-Immunadsorption.

Mittels Immunadsorption (IA) können Immunglobuline und Immunkomplexe aus dem Plasma entfernt werden. Während dieses therapeutische Verfahren beim Pemphigus vulgaris bereits etabliert ist, wird es be...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA® (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST® (an Oral Contraceptive)

The objective of this study is to estimate exposure to the hormones norelgestromin, norgestrel, and ethinyl estradiol in healthy female volunteers across multiple commercial lots of EVRA®...

Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen

Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro

Anti-hormonal Therapie With or Without Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer

This is a multicenter, prospective, randomized, open-label, controlled phase II study to test the addition of the CDK4/6 inhibitor ribociclib to anti-hormonal treatment as maintenance ther...

Dual AntiPlatelet Therapie for Prevention of Periinterventional Embolic Events in TAVI

TAVI is increasingly adopted as standard treatment for many subgroups of patients with aortic stenosis. However, due to a lack of data there is yet no TAVI-specific guidance regarding the ...

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

This study evaluates the safety and effectiveness of the Intelligent Retinal Implants System (IRIS V2). Blind patient suffering from Retinitis Pigmentosa, Cone Rod Dystrophy, or Choroidere...

Companies [9 Associated Companies listed on BioPortfolio]

LTS LOHMANN Therapie-Systeme AG

LTS was originally a subsidiary of the Lohmann Group. Lohmann was founded in 1851 and is active in a wide range of business areas, including medical products, adhesive tape systems and nonwoven fabric...

Bio-Therapie, LLC

ICS Identcode Systeme AG

Unsere Kernkompetenz liegt in der Identtechnologie. Die Herausforderung der schnellen Entwicklung und Ausbreitung der Auto-ID Technologie meistern wir durch die permanente Weiterbildung unserer Mitarb...

Labor-Systeme Fllukiger AG

Nil

Dr. Paul Lohmann GmbH KG

After more than 110 years of continuous customer-orientated product development Dr. Paul Lohmann is today a medium sized highly efficient company producing inorganic and organic mineral compounds.The ...

More Information about "LTS LOHMANN Therapie-Systeme AG" on BioPortfolio

We have published hundreds of LTS LOHMANN Therapie-Systeme AG news stories on BioPortfolio along with dozens of LTS LOHMANN Therapie-Systeme AG Clinical Trials and PubMed Articles about LTS LOHMANN Therapie-Systeme AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LTS LOHMANN Therapie-Systeme AG Companies in our database. You can also find out about relevant LTS LOHMANN Therapie-Systeme AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record